InspireMD, Inc. Warrants
NSPRW
NSPRW was delisted on the 7th of July, 2021.
0 hedge funds and large institutions have $0 invested in InspireMD, Inc. Warrants in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.
100% less funds holding
Funds holding: 3 → 0 (-3)
100% less capital invested
Capital invested by funds: $12K → $0 (-$12K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$4K |
| 3 |
VF
Virtu Financial
New York
|
-$4K |
NSPRW Hedge Fund Activity: Q3 2021 in Review
0 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Warrants (NSPRW) for Q3 2021, worth a combined $0 — down 100% from $12K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of NSPRW and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was HRT Financial, exiting entirely with an estimated $4K sold.
- 0 institutional investors held InspireMD, Inc. Warrants (NSPRW) as of Q3 2021, down from 3 in Q2 2021.
- Funds reported $0 of InspireMD, Inc. Warrants stock for Q3 2021, down 100% quarter-over-quarter.
- 0 funds opened new InspireMD, Inc. Warrants positions in Q3 2021 and 3 closed out, a net change of -3 holders.
- The largest InspireMD, Inc. Warrants seller in Q3 2021 was HRT Financial, an estimated $4K sold.
Based on aggregated 13F filings for Q3 2021.